These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3474046)

  • 1. Assessment of serum CA 19.9 as a tumour marker in patients with carcinoma of the bladder and prostate.
    Abel PD; Cornell C; Buamah PK; Williams G
    Br J Urol; 1987 May; 59(5):427-9. PubMed ID: 3474046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of CA-50 radioimmunoassay test in diagnosis of urologic malignancy. Tie for second place Jobst award.
    Hershman MJ; Habib NA; Ferro MA; Williamson RC; Wood CB
    Am Surg; 1987 Dec; 53(12):691-4. PubMed ID: 3480697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA-50 as tumour marker in transitional bladder carcinoma.
    Tizzani A; Casetta G; Piana P; Piantino P
    Br J Urol; 1989 Jun; 63(6):616-8. PubMed ID: 2752254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood and urinary values of CEA and CA 19-9 in patients with bladder carcinoma].
    Cicigoi A; Rocca Rossetti S; Piantino P; Cerchier A
    Minerva Med; 1986 Nov; 77(42-43):1983-7. PubMed ID: 3464851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of ABH surface antigens in superficial and invasive bladder neoplasma: inferences for the mechanism of tumor progression].
    Srougi M; Alves VA; Gayotto LC; Arap S
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(1):24-7. PubMed ID: 3547591
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell surface antigen -- a study in bladder tumours.
    Kulkarni JN; Kamat MR; Gangal SG; Talwalkar GV
    J Surg Oncol; 1982 Jan; 19(1):14-17. PubMed ID: 7057638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservation or loss of membrane antigens of the ABH blood group and their precursor substance. Prognostic importance for tumors of the bladder].
    Hammou JC; Fella C; Vacant J
    Acta Urol Belg; 1983; 51(1):12-7. PubMed ID: 6858793
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics.
    Fradet Y; Cordon-Cardo C; Whitmore WF; Melamed MR; Old LJ
    Cancer Res; 1986 Oct; 46(10):5183-8. PubMed ID: 3756873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor markers in bladder cancer.
    Huben RP
    Urology; 1984 Mar; 23(3 Suppl):10-4. PubMed ID: 6367189
    [No Abstract]   [Full Text] [Related]  

  • 11. Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
    Heyderman E; Brown BM; Richardson TC
    J Clin Pathol; 1984 Dec; 37(12):1363-9. PubMed ID: 6392348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
    Cruickshank DJ; Fullerton WT; Klopper A
    Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origin of carcinomas causing bladder neck obstruction demonstrated by immunoperoxidase localisation of specific antigens.
    Al Adnani MS
    Br J Urol; 1986 Jun; 58(3):283-6. PubMed ID: 3521781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-associated antigen CA 125 in patients with ovarian cancer.
    Heinonen PK; Tontti K; Koivula T; Pystynen P
    Br J Obstet Gynaecol; 1985 May; 92(5):528-31. PubMed ID: 3857939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
    Vafier JA; Javadpour N; Worsham GF; O'Connell KJ
    Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic evaluation of patients with cancer of the bladder by detection of ABH surface antigens].
    Srougi M; Alves VA; Gayotto LC; Raia S; Arap S
    AMB Rev Assoc Med Bras; 1987; 33(3-4):67-70. PubMed ID: 3501142
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice.
    Ford TF; Butcher DN; Masters JR; Parkinson MC
    Br J Urol; 1985 Feb; 57(1):50-5. PubMed ID: 2578846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)].
    Vallancien G; Rouger P; Leclerc JP; Kuss R
    Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface antigen in bilharzial bladder tumours.
    Halim A; Javadpour N; Kasraeian A; Young JD
    Br J Urol; 1986 Oct; 58(5):523-5. PubMed ID: 3096417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach.
    Sadoughi N; Rubenstone A; Mlsna J; Davidsohn I
    J Urol; 1980 Jan; 123(1):19-21. PubMed ID: 6985978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.